INTRODUCTION
============

Chronic infection with the bacteria *Helicobacter pylori* can cause many gastric diseases, including peptic ulcers and chronic gastritis, which can extend to gastric cancers.[@B1]-[@B3] Moreover, it has been repeatedly reported that *H. pylori* infections are associated with several extragastric conditions, such as cardiovascular diseases, pulmonary diseases, neurological diseases and hematological disorders.[@B4]-[@B6] In regards to cardiovascular or cerebrovascular diseases, *H. pylori* infections have been shown to be associated with stroke and coronary heart disease as a result of the atherosclerotic changes in blood vessels that arise from a chronic inflammatory response. However, many of these studies have focused on the relationship between overt diseases and *H. pylori* infection.[@B6]-[@B9]

In the case of coronary heart disease, the quiescent gap between asymptomatic atherosclerotic change and symptomatic coronary heart disease should be screened for more aggressively, and practitioners should recommend life style modifications to patients to reduce the likelihood of further morbidity.[@B10] Coronary artery calcium (CAC) levels reported by computed tomography (CT) scans are widely accepted as reproducible and reliable markers for coronary heart disease risk;[@B11],[@B12] furthermore, CAC score is especially useful for the detection of early stage coronary atherosclerosis. According to their CAC score, a subclinical patient can be recommended life style changes and/or medication for the effective prevention of coronary heart disease.[@B13],[@B14]

The evaluation of *H. pylori* infection is important for the promotion of the health of the general population, as well as for the prevention of coronary heart disease. Measuring serum immunoglobulin G antibody to *H. pylori* is most commonly used for population-based studies, and its accuracy has been sufficiently established through many studies across a diverse range of ethnic groups and countries, including South Korea.[@B15]-[@B17] Even though CAC score and *H. pylori* serology are acceptable tests under screening conditions, to the best of our knowledge, there have not been any studies that have revealed the relationship between *H. pylori* infection and coronary atherosclerosis using these tests. Therefore, we investigated the association between *H. pylori* seropositivity and CAC score in the screening population.

MATERIALS AND METHODS
=====================

1. Subjects and ethics
----------------------

We carried out a retrospective, cross-sectional case-control study. Between October 2003 and July 2007, 49,147 subjects (26,588 males, 22,559 females) visited the Seoul National University Hospital Healthcare System Gangnam Center for a routine health check-up. All of the data acquired from the check-ups were collected through an electronic medical record and stored in a data warehouse named HEALTHWATCH® version 1.0 (Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea). We retrieved the data for and enrolled 2,029 subjects who had previously undergone their health check-ups; which included CAC scores recorded with multidetector CT, and serological tests for anti-*H. pylori* antibody immunoglobulin G, both tests had been performed on the same day (between October 2003 and July 2007). We excluded the subjects who had a history of coronary heart disease or acute chest pain.[@B18]

This study protocol was approved by the Institutional Review of Board (IRB) of Seoul National University Hospital (IRB No. H-1010-031-335).

2. Check-up programs in detail
------------------------------

### 1) A structured questionnaire for the analysis of pertinent health and life style factors

The questionnaire consisted of demographic information, past and current medical history, socioeconomic status, and a systematized review of symptoms including acute chest pain, questions on diet, smoking habits (current smokers; defined as having smoked greater than or equal to 100 cigarettes in their lifetime and who smoked every day or on some days around the time of examination)[@B19] and alcohol consumption (≥140 g/wk or ≥20 g/day).[@B20]

### 2) Anthropometric measurements and evaluation for conventional cardiovascular risks

All subjects underwent physical measurements by trained personnel with standardized instruments. Body mass index (BMI) was calculated from weight and height and then categorized according to the modified World Health Organization (WHO) criteria from the Asia-Pacific guidelines.[@B21],[@B22] Waist circumference was measured within the WHO recommended area; i.e., the midpoint between the lower border of the rib cage and the iliac crest.[@B22] On the same day, after 12 hour fasting, we also measured blood pressure and performed laboratory tests for levels of total cholesterol, triglyceride, high density lipoprotein (HDL) cholesterol, fasting serum glucose, glycosylated hemoglobin (hemoglobin A1c, HbA1c), C-reactive protein (CRP), and uric acid.

Subjects were classified with metabolic syndrome by the presence of three or more of the following criteria: 1) abdominal obesity (waist circumference \>90 cm in males and \>80 cm in females, as defined in the Regional Office of the Western Pacific Region of World Health Organization (WPRO) waist circumference criteria \[National Cholesterol Education Program Adult Treatment Panel III\]); 2) blood pressure (BP) ≥130/85 mm Hg; 3) fasting serum glucose ≥100 mg/dL; 4) serum triglyceride ≥150 mg/dL; 5) HDL-cholesterol \<40 mg/dL in males or \<50 mg/dL in females.[@B21]

### 3) Serological test for anti-*H. pylori* antibody immunoglobulin G

Anti-*H. pylori* antibody immunoglobulin G (anti-*H. pylori* Ab Ig G) was measured using an enzyme linked immunosorbent assay kit (Radim Diagnostics, Rome, Italy) and an automatic analyzer, Alisei® (Seac, Pomezia, Italy). *H. pylori* seropositivity was determined according to the manufacturer\'s instructions.

### 4) Coronary artery calcium scores recorded using multidetector CT

Scanning of the coronary artery was performed using a 16-row multi-slice CT scanner (Sensation 16; Siemens Medical Systems, Erlangen, Germany). Following a topogram of the chest, a calcium score scan was performed using a retrospective method with a tube voltage of 120 kV, and 110 effective mAs with a 200 mm field of view.[@B23] Data were reconstructed to a 3-mm slice thickness at a -400 ms acquisition window. Calcium score analysis was performed onsite on a dedicated workstation using the analysis software Wizard VB10B® (Somaris/5 VB10B-W, SynGo; Siemens). Quantitative CAC scores were calculated according to the method described by Agatston et al.[@B24]

3. Statistical analysis
-----------------------

The continuous variables in this study were expressed as means with standard deviations (SD). In between-group comparisons, continuous variables were analyzed by Student\'s *t*-test and categorical variables by chi-square test. Logistic regression analysis was performed to evaluate the statistical significances of conventional cardiovascular risk factors and probable variables on CAC score. Each variable was given as an odds ratio (OR) with a 95% confidence interval (CI). A two tailed p-value of less than 0.05 was considered statistically significant. Statistical analysis was conducted using the SPSS version 12.0 (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

1. Clinical characteristics and CAC score with regards to *H. pylori* seropositivity
------------------------------------------------------------------------------------

A total of 2,029 subjects (1,295 males, 734 females, age 60.4±7.9) were enrolled in this study. They were divided into two groups according to *H. pylori*-seropositivity; classified as either HP-positive (anti-*H. pylori* Ab Ig G positive) or HP-negative (anti-*H. pylori* Ab Ig G negative). There were 1,214 (59.8%) HP-positive and 815 (40.2%) HP-negative subjects, respectively.

The clinical characteristics of each *H. pylori* seropositivity group are presented in [Table 1](#T1){ref-type="table"}. Baseline characteristics were not significantly different between HP-positive and HP-negative subjects. Moreover, there were no significant differences between the groups in the prevalence of metabolic syndrome, in most of the laboratory tests (except HDL-cholesterol level), and in mean CAC scores. The HP-positive group had a significantly lower mean HDL-cholesterol level (p=0.010), and a significantly higher number of subjects with a CAC score \>0 (p=0.037). Diabetes was more prevalent in the HP-positive group, but the difference was not statistically significant (p=0.088).

Mean CAC score was not significantly different between the HP-positive and HP-negative groups (p=0.449). The percentile distribution of CAC score according to *H. pylori* seropositivity is presented in [Table 2](#T2){ref-type="table"}. The difference of their means and SD was not statistically apparent in these studies since the distribution was highly skewed to upper score and its range was from zero to 5,060.

2. Clinical characteristics according to presence of CAC score (CAC score \>0)
------------------------------------------------------------------------------

The subjects were divided into two groups according to their CAC scores: the absence of a CAC score group (CAC score=0; Absence-CAC) and the presence of a CAC score group (CAC score \>0; Presence-CAC). The clinical characteristics of each group are displayed in [Table 3](#T3){ref-type="table"}. There were 1,269 (62.5%) subjects in the Absence-CAC and 760 (37.5%) in the Presence-CAC. The presence of a CAC score was significantly associated with multiple baseline characteristics such as age (p\<0.001), sex (p\<0.001), smoking (p\<0.001), alcohol (p=0.047), diabetes (p\<0.001), hypertension (p\<0.001), BMI (p\<0.001), waist circumference (p\<0.001), systolic BP (p\<0.001), and diastolic BP (p\<0.001). From the laboratory parameters, the presence of a CAC score was also significantly related to serum triglyceride (p\<0.001), HDL-cholesterol (p\<0.001), fasting glucose (p\<0.001), HbA1c (p\<0.001), uric acid (p\<0.001), and *H. pylori* seropositivity (p=0.037). Serum total cholesterol (p=0.858) and CRP (p=0.224) were not significantly different between the Absence-CAC and Presence-CAC groups.

3. Univariate and multivariate analyses of the relationship between coronary risk factors and the presence of a CAC score
-------------------------------------------------------------------------------------------------------------------------

We conducted a logistic regression analysis to test for possible independent associations between the detected variables and the presence of a CAC score; the results are presented in [Table 4](#T4){ref-type="table"}. In the multivariate model, we included the variables that were statistically significant in the unadjusted univariate analysis, which were: age, sex, BMI, smoking, alcohol, diabetes, hypertension, serum triglyceride, HDL-cholesterol, and *H. pylori* seropositivity. Among these variables, several were independently associated with the presence of a CAC score in the multivariate logistic regression analysis. The significant variables (p-value, odds ratio with 95% confidence interval) were age (p\<0.001; OR, 1.10; 95% CI, 1.08 to 1.11), sex (p\<0.001; OR, 2.91; 95% CI, 2.29 to 3.70), *H. pylori* seropositivity (p=0.049; OR, 1.23; 95% CI, 1.001 to 1.51), hypertension (p\<0.001; OR, 1.65; 95% CI, 1.34 to 2.03), diabetes (p=0.003; OR, 1.51; 95% CI, 1.15 to 1.97), smoking (p=0.002; OR, 1.49; 95% CI, 1.16 to 1.91), and serum triglyceride level (p=0.016; OR, 1.002; 95% CI, 1.000 to 1.003).

4. Analyses of *H. pylori* seropositivity against the severity categories of CAC score
--------------------------------------------------------------------------------------

Multivariate analysis conducted on the categorization of Absence-CAC (CAC score=0) and Presence-CAC (CAC score \>0) verified an independent association between *H. pylori* seropositivity and the presence of a CAC score (p=0.049; OR 1.23; 95% CI 1.001 to 1.51) ([Table 4](#T4){ref-type="table"} and detailed in [Table 5](#T5){ref-type="table"}).

To evaluate the association between *H. pylori* seropositivity and CAC score, CAC scores were stratified into four categories according to their severities.[@B12]-[@B14] The severity categories were absence (CAC score=0), mild (0\<CAC score≤10), moderate (10\<CAC score≤100), and severe (100\<CAC score). The results of the univariate and multivariate analyses of *H. pylori* seropositivity against the CAC severity categories are shown in [Table 6](#T6){ref-type="table"}. *H. pylori* seropositivity was strongly associated with the mild CAC category (0\<CAC score≤10) (p=0.004; OR, 1.82; 95% CI, 1.22 to 2.73). However, this association was no longer discernible in the progressed CAC score categories: moderate (10\<CAC score≤100) or severe (100\<CAC score).

DISCUSSION
==========

To the best of our knowledge, this is the first study clarifying the association between *H. pylori* seropositivity and CAC scores in a general asymptomatic population. Seropositivity for *H. pylori* antibody G within the study population was significantly related to the presence of CAC; especially for the mild CAC category, i.e., to early coronary atherosclerosis in asymptomatic subjects. Since chronic infections are known to be a predisposing factor for the development of coronary heart disease, there has been a continuous effort to investigate the relationship between *H. pylori* infection and coronary heart disease.[@B7],[@B9],[@B25]-[@B27] Most of the studies have been conducted on diseased subjects and only revealed a weak association, which became further confused by multivariate analysis. Furthermore, those studies conducted on young healthy subjects did not find any association between *H. pylori* infection and coronary vessel dysfunction.[@B28],[@B29] This might have originated from too many confounding variables related to the overt disease and the inappropriate selection of screening methods during the subclinical stage. CAC scores regard the overall burden of coronary atherosclerosis in patients, rather than the diagnosis of specific diseased vessels. Therefore, categorized CAC scores are currently being used as a guideline for suggesting life style changes, for recommendations regarding aspirin consumption and for the monitoring of the health of the general population.[@B13],[@B14] It was not surprising that, *H. pylori* seropositivity was not significantly associated with the manifestation of moderate to severe CAC, since coronary atherosclerosis is a multi-factorial disease. However, the strong relationship between *H. pylori* infection and a mild CAC score suggests that *H. pylori* infection can play a role in early atherosclerosis, independently, as well as the many traditional risk factors.

*H. pylori* infection can cause vascular disease directly, as a pathogen of vessel walls,[@B30],[@B31] or indirectly, through the inflammatory process.[@B32] Regarding inflammation and atherosclerosis as a result of *H. pylori* infection, acute vascular events, such as plaque disruption and endothelial desquamation, occur in advanced atherosclerotic vessels as a result of the actions of various inflammatory markers. In most of the previous studies conducted, symptomatic subjects have presented with elevated levels of inflammatory markers.[@B26],[@B33],[@B34] In the present study, we could not discern the relationship between *H. pylori* infection, and acute vascular events or CRP; therefore, our results neither support nor oppose the hypothesis that *H. pylori* can cause early stage atherosclerosis through the inflammatory pathway. The significantly lower mean HDL-cholesterol in the HP-positive group, compared to the negative group, suggests that endothelial dysfunction might have a relationship with *H. pylori* infection. Indeed, some studies have found lipid profile changes and endothelial dysfunction in *H. pylori* infected subjects;[@B25],[@B35] furthermore, in these studies, the lipid profile improved after eradication of *H. pylori* infection.[@B36],[@B37]

Our study has several advantages over previous clinical studies. First, this study was carried out in an asymptomatic general population. Usually, studies conducted on symptomatic study populations can blur the association between *H. pylori* and coronary heart disease. The subjects enrolled in this study were asymptomatic and subclinical, and, therefore, it was possible to elucidate upon the association between early coronary atherosclerosis and *H. pylori* infection. Second, we selected an appropriate screening tool for investigating early coronary atherosclerosis. CAC score, measured using CT, is a well validated tool for recording the multiple surrogate markers of coronary heart disease among an asymptomatic Korean population.[@B38] Third, our health check-up program simultaneously recorded the traditional risk factors of coronary heart disease, as well as other potential risk factors. Therefore, we could test for covariation among the traditional risk factors as well as those not yet reported.

There were also limitations to this study. First, there is a gap between *H. pylori* seropositivity and the real ongoing infection. Although there have always been debates regarding the gold standard tests for *H. pylori* infection, the serological test for *H. pylori* is the test most commonly adopted in a mass investigation.[@B15]-[@B17] Second, since this was a cross-sectional study, we could not elucidate upon the mechanism by which *H. pylori* infection causes coronary heart disease. To discover this mechanism, we need to perform a prospective cohort model study. In addition, some cross sectional studies are being designed to investigate early atherosclerosis in organs other than coronary vessels.

In conclusion, our study revealed an association between *H. pylori* seropositivity and the presence of a CAC score in the subclinical circumstances, and suggested that *H. pylori* infection could be related to the early stages of coronary atherosclerosis rather than advanced coronary atherosclerosis.
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Comparison of Clinical Characteristics according to *H. pylori* Seropositivity
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Data are presented as the mean±SD or number (%).

HP, *H. pylori*; HP-positive, *H. pylori* seropositivity; HP-negative, *H. pylori* seronegativity; BMI, body mass index; BP, blood pressure; HbA1c, glycosylated hemoglobin, hemoglobin A1c; HDL, high density lipoprotein; CRP, C-reactive protein; CAC, coronary artery calcium.
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Distribution of Coronary Artery Calcium Scores according to *H. pylori* Seropositivity
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Data are presented as the mean±SD.

CAC, coronary artery calcium; HP, *H. pylori*; HP-positive, *H. pylori* seropositivity; HP-negative, *H. pylori* seronegativity.

^\*^p-value is from Student\'s *t*-test.
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Comparison of Clinical Characteristics according to the Score for Presence of Coronary Artery Calcium
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Date are presented as the mean±SD or number (%).

CAC, coronary artery calcium; BMI, body mass index; BP, blood pressure; HbA1c, glycosylated hemoglobin, hemoglobin A1c; CRP, C-reactive protein; HP, *H. pylori*.
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Univariate and Multivariate Analyses of Coronary Risk Factors and Coronary Artery Calcium Score
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OR, odds ratio; CI, confidence interval; CAC, coronary artery calcium; HP, *H. pylori*; HP-positive, *H. pylori* seropositivity; HP-negative, *H. pylori* seronegativity; HDL, high density lipoprotein; BMI, body mass index.

^\*^Multivariate model for age, sex, BMI, smoking, alcohol, diabetes, hypertension, triglyceride, HDL-cholesterol.
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Univariate and Multivariate Analyses of *H. pylori* Seropositivity and Coronary Artery Calcium Score
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OR, odds ratio; CI, confidence interval; CAC, coronary artery calcium; HP, *H. pylori*; HP-positive, *H. pylori* seropositivity; HP-negative, *H. pylori* seronegativity.

^\*^Multivariate model for age, sex, body mass index (BMI), smoking, alcohol, diabetes, hypertension, triglyceride, high density lipoprotein (HDL)-cholesterol.
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Univariate and Multivariate Analyses of *H. pylori* Seropositivity according to Coronary Artery Calcium Score Severity Categories
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OR, odds ratio; CI, confidence interval; CAC, coronary artery calcium; HP, *H. pylori*; HP-positive, *H. pylori* seropositivity; HP-negative, *H. pylori* seronegativity; CACS, CAC score.

^\*^Multivariate model for age, sex, body mass index (BMI), smoking, alcohol, diabetes, hypertension, triglyceride, high density lipoprotein (HDL)-cholesterol.
